1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in Europe, July 2020

Mental Health Analysis & Statistics in Europe, July 2020

1-30 of 67 reports

Global Behavioral/Mental Health Software Industry

  • $ 5450
  • July 2020
  • 205 pages

Global Behavioral/Mental Health Software Market to Reach US$3.7 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Behavioral/Mental Health Software estimated at US$1.5 Billion in ...

  • Mental Health
  • Pathology
  • Europe
  • World
  • Demand

Europe Rare Neurological Disease Treatment Market to 2027 - Regional Analysis and Forecasts by Indication ; Drug Type ; Distribution Channel ; Mode of Administration and Country

  • $ 3000
  • April 2020
  • 154 pages

Europe, the rare neurological disease treatment market, is anticipated to reach US$ 3,763.41 Mn in 2027 from US$ 2,048.10 Mn in 2019. The market is projected to grow with a CAGR of 8.1% from 2020-2027. The ...

  • Mental Health
  • Europe
  • Market Size
  • Allergan plc
  • Bayer AG

Europe Deep Brain Stimulation Devices Market By Applications By End User By Country, Industry Analysis and Forecast, 2019 - 2025

  • $ 1500
  • March 2020
  • 76 pages

The Europe Deep Brain Stimulation Devices Market would witness market growth of 15.7% CAGR during the forecast period (2019-2025). Each year over 50 000 Europeans are diagnosed with Parkinson’s disease. ...

  • Mental Health
  • Pathology
  • Europe

Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 51 pages

Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H1 2020 Summary Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity ...

  • Mental Health
  • Therapy
  • Europe
  • Product Initiative
  • Dompe Farmaceutici S.p.A.

Europe Narcolepsy Market to 2027 - Regional Analysis and Forecasts By Type ; Product ; Distribution Channel and Country

  • $ 3000
  • January 2020
  • 123 pages

Europe, the narcolepsy market, is anticipated to reach US$ 1,532.5 Mn in 2027 from US$ 671.1 Mn in 2018. The market is projected to grow with a CAGR of 9.7% from 2019-2027. The European narcolepsy market ...

  • Mental Health
  • Europe
  • Forecast
  • Market Size
  • Takeda Pharmaceutical Company Limited

EUROPE ALZHEIMER’S THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2020-2028

  • $ 1250
  • January 2020
  • 155 pages

KEY FINDINGS The market of Alzheimer’s disease therapeutics and diagnostics of Europe is projected to register a CAGR of 5.42% over the projected period of 2020-2028. The rising geriatric population ...

  • Mental Health
  • Therapy
  • Europe
  • Forecast
  • Market Size

Alpha 2C Adrenergic Receptor - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 49 pages

Alpha 2C Adrenergic Receptor - Pipeline Review, H2 2019 Summary Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Alpha-2C adrenergic recepto ...

  • Antipsychotic
  • Mental Health
  • Europe
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 39 pages

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Sandhoff Disease (Jatzkewitz-Pilz Syndrome) - Pipeline Review, ...

  • Mental Health
  • Neurological Disorder
  • Europe
  • Product Initiative
  • Polaryx Therapeutics, Inc

Canavan Disease - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 36 pages

Canavan Disease - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Pipeline Review, H2 2019, provides an overview of the Canavan Disease ...

  • Mental Health
  • Neurological Disorder
  • Europe
  • Product Initiative
  • Pfizer Inc.

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Mental Health
  • Pathology
  • Europe
  • France
  • Demand

Global Dravet Syndrome Market: Industry Analysis & Outlook (2019-2023)

  • $ 800
  • February 2019
  • 62 pages

Dravet syndrome, formerly known as severe myoclonic epilepsy of infancy (SMEI), is a severe kind of epilepsy which causes seizures. High fever is usually a trigger for these seizures. It is a rare disorde ...

  • Mental Health
  • Europe
  • World
  • Forecast
  • GW Pharmaceuticals plc

AB Science SA (AB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 77 pages

Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors.The company’s lead compound Masitinib, is a orally administered ...

  • Dementia
  • Mental Health
  • Therapy
  • Europe
  • AB Science SA

NeuroDerm Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 39 pages

Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system ...

  • Mental Health
  • Psychotic Disorder
  • Europe
  • Product Initiative
  • NeuroDerm Ltd.

NeuroDerm Ltd - Product Pipeline Analysis, 2018 Update

  • $ 750
  • September 2018
  • 39 pages

Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system ...

  • Mental Health
  • Europe
  • Company Operations
  • Product Initiative
  • NeuroDerm Ltd.

Inbrija

  • $ 10000
  • June 2018
  • 15 pages

Drug Overview Inbrija (Acorda Therapeutics) is an inhaled formulation of levodopa, in development as an adjunct to existing oral levodopa formulations in patients experiencing motor fluctuations. Levodopa ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • United States

Azilect

  • $ 10000
  • June 2018
  • 16 pages

Drug Overview Azilect (Teva/Lundbeck/Takeda) contains the pure R-isomer of rasagiline and acts as a selective irreversible monoamine oxidase inhibitor (MAOI), with up to 10 times more potency than selegiline ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • United States

EUROPE ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2018-2026

  • $ 1354
  • April 2018
  • 4 pages

KEY FINDINGS The Europe Alzheimer’s disease therapeutics and diagnostics market is likely to progress with a 7.62% CAGR over the forecast period of 2018-2026.The region is expected to primarily become ...

  • Dementia
  • Mental Health
  • Therapy
  • Europe
  • Market Size

Alzheimer’s Disease: Update Bulletin [January 2018]

  • $ 1151
  • January 2018
  • 1 pages

This edition presents the views and insights from three world leading key opinion leaders (KOLs) from North America and Europe on a variety of recent events in Alzheimer’s disease (AD) market, including; ...

  • Dementia
  • Mental Health
  • Pathology
  • Therapy
  • Europe

Europe Multiple Sclerosis Market, Patients By (United Kingdom, Germany, France, Italy, Spain) By (Injectables, Infusion, Orals)

  • $ 1400
  • October 2017
  • 86 pages

According to Renub Research Europe Multiple Sclerosis Market potential is more than US$ 5 Billion by 2022. But only more than half this market is expected to be actually achieved. This huge difference ...

  • Mental Health
  • Neurological Disorder
  • Therapy
  • Europe
  • Forecast

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Depression
  • Mental Health
  • Pathology
  • Europe
  • Forecast

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • Forecast

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • France

Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Panic Disorder patients study in a new report ‘Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Panic ...

  • Anxiety Disorder
  • Mental Health
  • Pathology
  • Europe
  • Forecast

Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Obsessive Compulsive Disorder patients study in a new report ‘Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Mental Health
  • Pathology
  • Personality Disorder
  • Europe
  • France

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Europe
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Major Depression patients study in a new report ‘Europe Major Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Depression
  • Mental Health
  • Pathology
  • Europe
  • Forecast

Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Dementia
  • Mental Health
  • Pathology
  • Europe
  • France

Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Gaucher's Disease patients study in a new report ‘Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Europe
  • France

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Europe
  • Forecast

Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Bipolar Disorder patients study in a new report ‘Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Europe
  • Forecast

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on